Global Liposomes Drug Delivery Supply, Demand and Key Producers, 2024-2030

Description

The global Liposomes Drug Delivery market size is expected to reach $ 6506.7 million by 2030, rising at a market growth of 9.6% CAGR during the forecast period (2024-2030).

North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.

Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

This report studies the global Liposomes Drug Delivery production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Liposomes Drug Delivery, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liposomes Drug Delivery that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Liposomes Drug Delivery total production and demand, 2019-2030, (K Vials)
Global Liposomes Drug Delivery total production value, 2019-2030, (USD Million)
Global Liposomes Drug Delivery production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Vials)
Global Liposomes Drug Delivery consumption by region & country, CAGR, 2019-2030 & (K Vials)
U.S. VS China: Liposomes Drug Delivery domestic production, consumption, key domestic manufacturers and share
Global Liposomes Drug Delivery production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Vials)
Global Liposomes Drug Delivery production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Vials)
Global Liposomes Drug Delivery production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Vials).

This reports profiles key players in the global Liposomes Drug Delivery market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical and CSPC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Liposomes Drug Delivery market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Vials) and average price (USD/Vial) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Liposomes Drug Delivery Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Liposomes Drug Delivery Market, Segmentation by Type
    Liposomal Doxorubicin
    Liposomal Amphoteracin B
    Liposomal Paclitaxel
    Others

Global Liposomes Drug Delivery Market, Segmentation by Application
    Fungal Infection Therapy
    Cancer & Tumor Therapy
    Others

Companies Profiled:
    Johnson & Johnson
    Gilead Sciences
    Pacira
    Sun Pharmaceutical
    Luye Pharma
    Sigma-Tau Group
    Fudan-Zhangjiang
    Teva Pharmaceutical
    CSPC
    Novartis
    Kingond Pharm
    Spectrum Pharmaceuticals
    Shanghai New Asia

Key Questions Answered
1. How big is the global Liposomes Drug Delivery market?
2. What is the demand of the global Liposomes Drug Delivery market?
3. What is the year over year growth of the global Liposomes Drug Delivery market?
4. What is the production and production value of the global Liposomes Drug Delivery market?
5. Who are the key producers in the global Liposomes Drug Delivery market?

Table of Contents

1 Supply Summary
    1.1 Liposomes Drug Delivery Introduction
    1.2 World Liposomes Drug Delivery Supply & Forecast
        1.2.1 World Liposomes Drug Delivery Production Value (2019 & 2023 & 2030)
        1.2.2 World Liposomes Drug Delivery Production (2019-2030)
        1.2.3 World Liposomes Drug Delivery Pricing Trends (2019-2030)
    1.3 World Liposomes Drug Delivery Production by Region (Based on Production Site)
        1.3.1 World Liposomes Drug Delivery Production Value by Region (2019-2030)
        1.3.2 World Liposomes Drug Delivery Production by Region (2019-2030)
        1.3.3 World Liposomes Drug Delivery Average Price by Region (2019-2030)
        1.3.4 North America Liposomes Drug Delivery Production (2019-2030)
        1.3.5 Europe Liposomes Drug Delivery Production (2019-2030)
        1.3.6 Middle East & Africa Liposomes Drug Delivery Production (2019-2030)
        1.3.7 Japan Liposomes Drug Delivery Production (2019-2030)
        1.3.8 China Liposomes Drug Delivery Production (2019-2030)
        1.3.9 India Liposomes Drug Delivery Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Liposomes Drug Delivery Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Liposomes Drug Delivery Major Market Trends

2 Demand Summary
    2.1 World Liposomes Drug Delivery Demand (2019-2030)
    2.2 World Liposomes Drug Delivery Consumption by Region
        2.2.1 World Liposomes Drug Delivery Consumption by Region (2019-2024)
        2.2.2 World Liposomes Drug Delivery Consumption Forecast by Region (2025-2030)
    2.3 United States Liposomes Drug Delivery Consumption (2019-2030)
    2.4 China Liposomes Drug Delivery Consumption (2019-2030)
    2.5 Europe Liposomes Drug Delivery Consumption (2019-2030)
    2.6 Japan Liposomes Drug Delivery Consumption (2019-2030)
    2.7 South Korea Liposomes Drug Delivery Consumption (2019-2030)
    2.8 ASEAN Liposomes Drug Delivery Consumption (2019-2030)
    2.9 India Liposomes Drug Delivery Consumption (2019-2030)

3 World Liposomes Drug Delivery Manufacturers Competitive Analysis
    3.1 World Liposomes Drug Delivery Production Value by Manufacturer (2019-2024)
    3.2 World Liposomes Drug Delivery Production by Manufacturer (2019-2024)
    3.3 World Liposomes Drug Delivery Average Price by Manufacturer (2019-2024)
    3.4 Liposomes Drug Delivery Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Liposomes Drug Delivery Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Liposomes Drug Delivery in 2023
        3.5.3 Global Concentration Ratios (CR8) for Liposomes Drug Delivery in 2023
    3.6 Liposomes Drug Delivery Market: Overall Company Footprint Analysis
        3.6.1 Liposomes Drug Delivery Market: Region Footprint
        3.6.2 Liposomes Drug Delivery Market: Company Product Type Footprint
        3.6.3 Liposomes Drug Delivery Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Liposomes Drug Delivery Production Value Comparison
        4.1.1 United States VS China: Liposomes Drug Delivery Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Liposomes Drug Delivery Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Liposomes Drug Delivery Production Comparison
        4.2.1 United States VS China: Liposomes Drug Delivery Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Liposomes Drug Delivery Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Liposomes Drug Delivery Consumption Comparison
        4.3.1 United States VS China: Liposomes Drug Delivery Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Liposomes Drug Delivery Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Liposomes Drug Delivery Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Liposomes Drug Delivery Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Liposomes Drug Delivery Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Liposomes Drug Delivery Production (2019-2024)
    4.5 China Based Liposomes Drug Delivery Manufacturers and Market Share
        4.5.1 China Based Liposomes Drug Delivery Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Liposomes Drug Delivery Production Value (2019-2024)
        4.5.3 China Based Manufacturers Liposomes Drug Delivery Production (2019-2024)
    4.6 Rest of World Based Liposomes Drug Delivery Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Liposomes Drug Delivery Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Liposomes Drug Delivery Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Liposomes Drug Delivery Production (2019-2024)

5 Market Analysis by Type
    5.1 World Liposomes Drug Delivery Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Liposomal Doxorubicin
        5.2.2 Liposomal Amphoteracin B
        5.2.3 Liposomal Paclitaxel
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Liposomes Drug Delivery Production by Type (2019-2030)
        5.3.2 World Liposomes Drug Delivery Production Value by Type (2019-2030)
        5.3.3 World Liposomes Drug Delivery Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Liposomes Drug Delivery Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Fungal Infection Therapy
        6.2.2 Cancer & Tumor Therapy
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Liposomes Drug Delivery Production by Application (2019-2030)
        6.3.2 World Liposomes Drug Delivery Production Value by Application (2019-2030)
        6.3.3 World Liposomes Drug Delivery Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Details
        7.1.2 Johnson & Johnson Major Business
        7.1.3 Johnson & Johnson Liposomes Drug Delivery Product and Services
        7.1.4 Johnson & Johnson Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Johnson & Johnson Recent Developments/Updates
        7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Details
        7.2.2 Gilead Sciences Major Business
        7.2.3 Gilead Sciences Liposomes Drug Delivery Product and Services
        7.2.4 Gilead Sciences Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Gilead Sciences Recent Developments/Updates
        7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.3 Pacira
        7.3.1 Pacira Details
        7.3.2 Pacira Major Business
        7.3.3 Pacira Liposomes Drug Delivery Product and Services
        7.3.4 Pacira Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Pacira Recent Developments/Updates
        7.3.6 Pacira Competitive Strengths & Weaknesses
    7.4 Sun Pharmaceutical
        7.4.1 Sun Pharmaceutical Details
        7.4.2 Sun Pharmaceutical Major Business
        7.4.3 Sun Pharmaceutical Liposomes Drug Delivery Product and Services
        7.4.4 Sun Pharmaceutical Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Sun Pharmaceutical Recent Developments/Updates
        7.4.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
    7.5 Luye Pharma
        7.5.1 Luye Pharma Details
        7.5.2 Luye Pharma Major Business
        7.5.3 Luye Pharma Liposomes Drug Delivery Product and Services
        7.5.4 Luye Pharma Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Luye Pharma Recent Developments/Updates
        7.5.6 Luye Pharma Competitive Strengths & Weaknesses
    7.6 Sigma-Tau Group
        7.6.1 Sigma-Tau Group Details
        7.6.2 Sigma-Tau Group Major Business
        7.6.3 Sigma-Tau Group Liposomes Drug Delivery Product and Services
        7.6.4 Sigma-Tau Group Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Sigma-Tau Group Recent Developments/Updates
        7.6.6 Sigma-Tau Group Competitive Strengths & Weaknesses
    7.7 Fudan-Zhangjiang
        7.7.1 Fudan-Zhangjiang Details
        7.7.2 Fudan-Zhangjiang Major Business
        7.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Product and Services
        7.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Fudan-Zhangjiang Recent Developments/Updates
        7.7.6 Fudan-Zhangjiang Competitive Strengths & Weaknesses
    7.8 Teva Pharmaceutical
        7.8.1 Teva Pharmaceutical Details
        7.8.2 Teva Pharmaceutical Major Business
        7.8.3 Teva Pharmaceutical Liposomes Drug Delivery Product and Services
        7.8.4 Teva Pharmaceutical Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Teva Pharmaceutical Recent Developments/Updates
        7.8.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
    7.9 CSPC
        7.9.1 CSPC Details
        7.9.2 CSPC Major Business
        7.9.3 CSPC Liposomes Drug Delivery Product and Services
        7.9.4 CSPC Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 CSPC Recent Developments/Updates
        7.9.6 CSPC Competitive Strengths & Weaknesses
    7.10 Novartis
        7.10.1 Novartis Details
        7.10.2 Novartis Major Business
        7.10.3 Novartis Liposomes Drug Delivery Product and Services
        7.10.4 Novartis Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Novartis Recent Developments/Updates
        7.10.6 Novartis Competitive Strengths & Weaknesses
    7.11 Kingond Pharm
        7.11.1 Kingond Pharm Details
        7.11.2 Kingond Pharm Major Business
        7.11.3 Kingond Pharm Liposomes Drug Delivery Product and Services
        7.11.4 Kingond Pharm Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Kingond Pharm Recent Developments/Updates
        7.11.6 Kingond Pharm Competitive Strengths & Weaknesses
    7.12 Spectrum Pharmaceuticals
        7.12.1 Spectrum Pharmaceuticals Details
        7.12.2 Spectrum Pharmaceuticals Major Business
        7.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Product and Services
        7.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Spectrum Pharmaceuticals Recent Developments/Updates
        7.12.6 Spectrum Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Shanghai New Asia
        7.13.1 Shanghai New Asia Details
        7.13.2 Shanghai New Asia Major Business
        7.13.3 Shanghai New Asia Liposomes Drug Delivery Product and Services
        7.13.4 Shanghai New Asia Liposomes Drug Delivery Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Shanghai New Asia Recent Developments/Updates
        7.13.6 Shanghai New Asia Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Liposomes Drug Delivery Industry Chain
    8.2 Liposomes Drug Delivery Upstream Analysis
        8.2.1 Liposomes Drug Delivery Core Raw Materials
        8.2.2 Main Manufacturers of Liposomes Drug Delivery Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Liposomes Drug Delivery Production Mode
    8.6 Liposomes Drug Delivery Procurement Model
    8.7 Liposomes Drug Delivery Industry Sales Model and Sales Channels
        8.7.1 Liposomes Drug Delivery Sales Model
        8.7.2 Liposomes Drug Delivery Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Liposomes Drug Delivery Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Liposomes Drug Delivery Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Liposomes Drug Delivery Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Liposomes Drug Delivery Production Value Market Share by Region (2019-2024)
    Table 5. World Liposomes Drug Delivery Production Value Market Share by Region (2025-2030)
    Table 6. World Liposomes Drug Delivery Production by Region (2019-2024) & (K Vials)
    Table 7. World Liposomes Drug Delivery Production by Region (2025-2030) & (K Vials)
    Table 8. World Liposomes Drug Delivery Production Market Share by Region (2019-2024)
    Table 9. World Liposomes Drug Delivery Production Market Share by Region (2025-2030)
    Table 10. World Liposomes Drug Delivery Average Price by Region (2019-2024) & (USD/Vial)
    Table 11. World Liposomes Drug Delivery Average Price by Region (2025-2030) & (USD/Vial)
    Table 12. Liposomes Drug Delivery Major Market Trends
    Table 13. World Liposomes Drug Delivery Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Vials)
    Table 14. World Liposomes Drug Delivery Consumption by Region (2019-2024) & (K Vials)
    Table 15. World Liposomes Drug Delivery Consumption Forecast by Region (2025-2030) & (K Vials)
    Table 16. World Liposomes Drug Delivery Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Liposomes Drug Delivery Producers in 2023
    Table 18. World Liposomes Drug Delivery Production by Manufacturer (2019-2024) & (K Vials)
    Table 19. Production Market Share of Key Liposomes Drug Delivery Producers in 2023
    Table 20. World Liposomes Drug Delivery Average Price by Manufacturer (2019-2024) & (USD/Vial)
    Table 21. Global Liposomes Drug Delivery Company Evaluation Quadrant
    Table 22. World Liposomes Drug Delivery Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Liposomes Drug Delivery Production Site of Key Manufacturer
    Table 24. Liposomes Drug Delivery Market: Company Product Type Footprint
    Table 25. Liposomes Drug Delivery Market: Company Product Application Footprint
    Table 26. Liposomes Drug Delivery Competitive Factors
    Table 27. Liposomes Drug Delivery New Entrant and Capacity Expansion Plans
    Table 28. Liposomes Drug Delivery Mergers & Acquisitions Activity
    Table 29. United States VS China Liposomes Drug Delivery Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Liposomes Drug Delivery Production Comparison, (2019 & 2023 & 2030) & (K Vials)
    Table 31. United States VS China Liposomes Drug Delivery Consumption Comparison, (2019 & 2023 & 2030) & (K Vials)
    Table 32. United States Based Liposomes Drug Delivery Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Liposomes Drug Delivery Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Liposomes Drug Delivery Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Liposomes Drug Delivery Production (2019-2024) & (K Vials)
    Table 36. United States Based Manufacturers Liposomes Drug Delivery Production Market Share (2019-2024)
    Table 37. China Based Liposomes Drug Delivery Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Liposomes Drug Delivery Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Liposomes Drug Delivery Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Liposomes Drug Delivery Production (2019-2024) & (K Vials)
    Table 41. China Based Manufacturers Liposomes Drug Delivery Production Market Share (2019-2024)
    Table 42. Rest of World Based Liposomes Drug Delivery Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Liposomes Drug Delivery Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Liposomes Drug Delivery Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Liposomes Drug Delivery Production (2019-2024) & (K Vials)
    Table 46. Rest of World Based Manufacturers Liposomes Drug Delivery Production Market Share (2019-2024)
    Table 47. World Liposomes Drug Delivery Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Liposomes Drug Delivery Production by Type (2019-2024) & (K Vials)
    Table 49. World Liposomes Drug Delivery Production by Type (2025-2030) & (K Vials)
    Table 50. World Liposomes Drug Delivery Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Liposomes Drug Delivery Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Liposomes Drug Delivery Average Price by Type (2019-2024) & (USD/Vial)
    Table 53. World Liposomes Drug Delivery Average Price by Type (2025-2030) & (USD/Vial)
    Table 54. World Liposomes Drug Delivery Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Liposomes Drug Delivery Production by Application (2019-2024) & (K Vials)
    Table 56. World Liposomes Drug Delivery Production by Application (2025-2030) & (K Vials)
    Table 57. World Liposomes Drug Delivery Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Liposomes Drug Delivery Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Liposomes Drug Delivery Average Price by Application (2019-2024) & (USD/Vial)
    Table 60. World Liposomes Drug Delivery Average Price by Application (2025-2030) & (USD/Vial)
    Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 62. Johnson & Johnson Major Business
    Table 63. Johnson & Johnson Liposomes Drug Delivery Product and Services
    Table 64. Johnson & Johnson Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Johnson & Johnson Recent Developments/Updates
    Table 66. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 68. Gilead Sciences Major Business
    Table 69. Gilead Sciences Liposomes Drug Delivery Product and Services
    Table 70. Gilead Sciences Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Gilead Sciences Recent Developments/Updates
    Table 72. Gilead Sciences Competitive Strengths & Weaknesses
    Table 73. Pacira Basic Information, Manufacturing Base and Competitors
    Table 74. Pacira Major Business
    Table 75. Pacira Liposomes Drug Delivery Product and Services
    Table 76. Pacira Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Pacira Recent Developments/Updates
    Table 78. Pacira Competitive Strengths & Weaknesses
    Table 79. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 80. Sun Pharmaceutical Major Business
    Table 81. Sun Pharmaceutical Liposomes Drug Delivery Product and Services
    Table 82. Sun Pharmaceutical Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Sun Pharmaceutical Recent Developments/Updates
    Table 84. Sun Pharmaceutical Competitive Strengths & Weaknesses
    Table 85. Luye Pharma Basic Information, Manufacturing Base and Competitors
    Table 86. Luye Pharma Major Business
    Table 87. Luye Pharma Liposomes Drug Delivery Product and Services
    Table 88. Luye Pharma Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Luye Pharma Recent Developments/Updates
    Table 90. Luye Pharma Competitive Strengths & Weaknesses
    Table 91. Sigma-Tau Group Basic Information, Manufacturing Base and Competitors
    Table 92. Sigma-Tau Group Major Business
    Table 93. Sigma-Tau Group Liposomes Drug Delivery Product and Services
    Table 94. Sigma-Tau Group Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Sigma-Tau Group Recent Developments/Updates
    Table 96. Sigma-Tau Group Competitive Strengths & Weaknesses
    Table 97. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
    Table 98. Fudan-Zhangjiang Major Business
    Table 99. Fudan-Zhangjiang Liposomes Drug Delivery Product and Services
    Table 100. Fudan-Zhangjiang Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Fudan-Zhangjiang Recent Developments/Updates
    Table 102. Fudan-Zhangjiang Competitive Strengths & Weaknesses
    Table 103. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 104. Teva Pharmaceutical Major Business
    Table 105. Teva Pharmaceutical Liposomes Drug Delivery Product and Services
    Table 106. Teva Pharmaceutical Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Teva Pharmaceutical Recent Developments/Updates
    Table 108. Teva Pharmaceutical Competitive Strengths & Weaknesses
    Table 109. CSPC Basic Information, Manufacturing Base and Competitors
    Table 110. CSPC Major Business
    Table 111. CSPC Liposomes Drug Delivery Product and Services
    Table 112. CSPC Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. CSPC Recent Developments/Updates
    Table 114. CSPC Competitive Strengths & Weaknesses
    Table 115. Novartis Basic Information, Manufacturing Base and Competitors
    Table 116. Novartis Major Business
    Table 117. Novartis Liposomes Drug Delivery Product and Services
    Table 118. Novartis Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Novartis Recent Developments/Updates
    Table 120. Novartis Competitive Strengths & Weaknesses
    Table 121. Kingond Pharm Basic Information, Manufacturing Base and Competitors
    Table 122. Kingond Pharm Major Business
    Table 123. Kingond Pharm Liposomes Drug Delivery Product and Services
    Table 124. Kingond Pharm Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Kingond Pharm Recent Developments/Updates
    Table 126. Kingond Pharm Competitive Strengths & Weaknesses
    Table 127. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 128. Spectrum Pharmaceuticals Major Business
    Table 129. Spectrum Pharmaceuticals Liposomes Drug Delivery Product and Services
    Table 130. Spectrum Pharmaceuticals Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Spectrum Pharmaceuticals Recent Developments/Updates
    Table 132. Shanghai New Asia Basic Information, Manufacturing Base and Competitors
    Table 133. Shanghai New Asia Major Business
    Table 134. Shanghai New Asia Liposomes Drug Delivery Product and Services
    Table 135. Shanghai New Asia Liposomes Drug Delivery Production (K Vials), Price (USD/Vial), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 136. Global Key Players of Liposomes Drug Delivery Upstream (Raw Materials)
    Table 137. Liposomes Drug Delivery Typical Customers
    Table 138. Liposomes Drug Delivery Typical Distributors
List of Figure
    Figure 1. Liposomes Drug Delivery Picture
    Figure 2. World Liposomes Drug Delivery Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Liposomes Drug Delivery Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Liposomes Drug Delivery Production (2019-2030) & (K Vials)
    Figure 5. World Liposomes Drug Delivery Average Price (2019-2030) & (USD/Vial)
    Figure 6. World Liposomes Drug Delivery Production Value Market Share by Region (2019-2030)
    Figure 7. World Liposomes Drug Delivery Production Market Share by Region (2019-2030)
    Figure 8. North America Liposomes Drug Delivery Production (2019-2030) & (K Vials)
    Figure 9. Europe Liposomes Drug Delivery Production (2019-2030) & (K Vials)
    Figure 10. Middle East & Africa Liposomes Drug Delivery Production (2019-2030) & (K Vials)
    Figure 11. Japan Liposomes Drug Delivery Production (2019-2030) & (K Vials)
    Figure 12. China Liposomes Drug Delivery Production (2019-2030) & (K Vials)
    Figure 13. India Liposomes Drug Delivery Production (2019-2030) & (K Vials)
    Figure 14. Liposomes Drug Delivery Market Drivers
    Figure 15. Factors Affecting Demand
    Figure 16. World Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 17. World Liposomes Drug Delivery Consumption Market Share by Region (2019-2030)
    Figure 18. United States Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 19. China Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 20. Europe Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 21. Japan Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 22. South Korea Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 23. ASEAN Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 24. India Liposomes Drug Delivery Consumption (2019-2030) & (K Vials)
    Figure 25. Producer Shipments of Liposomes Drug Delivery by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 26. Global Four-firm Concentration Ratios (CR4) for Liposomes Drug Delivery Markets in 2023
    Figure 27. Global Four-firm Concentration Ratios (CR8) for Liposomes Drug Delivery Markets in 2023
    Figure 28. United States VS China: Liposomes Drug Delivery Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States VS China: Liposomes Drug Delivery Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 30. United States VS China: Liposomes Drug Delivery Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 31. United States Based Manufacturers Liposomes Drug Delivery Production Market Share 2023
    Figure 32. China Based Manufacturers Liposomes Drug Delivery Production Market Share 2023
    Figure 33. Rest of World Based Manufacturers Liposomes Drug Delivery Production Market Share 2023
    Figure 34. World Liposomes Drug Delivery Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Liposomes Drug Delivery Production Value Market Share by Type in 2023
    Figure 36. Liposomal Doxorubicin
    Figure 37. Liposomal Amphoteracin B
    Figure 38. Liposomal Paclitaxel
    Figure 39. Others
    Figure 40. World Liposomes Drug Delivery Production Market Share by Type (2019-2030)
    Figure 41. World Liposomes Drug Delivery Production Value Market Share by Type (2019-2030)
    Figure 42. World Liposomes Drug Delivery Average Price by Type (2019-2030) & (USD/Vial)
    Figure 43. World Liposomes Drug Delivery Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 44. World Liposomes Drug Delivery Production Value Market Share by Application in 2023
    Figure 45. Fungal Infection Therapy
    Figure 46. Cancer & Tumor Therapy
    Figure 47. Others
    Figure 48. World Liposomes Drug Delivery Production Market Share by Application (2019-2030)
    Figure 49. World Liposomes Drug Delivery Production Value Market Share by Application (2019-2030)
    Figure 50. World Liposomes Drug Delivery Average Price by Application (2019-2030) & (USD/Vial)
    Figure 51. Liposomes Drug Delivery Industry Chain
    Figure 52. Liposomes Drug Delivery Procurement Model
    Figure 53. Liposomes Drug Delivery Sales Model
    Figure 54. Liposomes Drug Delivery Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Companies Mentioned

Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia